Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

A viral-vectored RSV vaccine induces long-lived humoral immunity in cotton rats.

Grieves JL, Yin Z, Garcia-Sastre A, Mena I, Peeples ME, Risman HP, Federman H, Sandoval MJ, Durbin RK, Durbin JE.

Vaccine. 2018 Jun 18;36(26):3842-3852. doi: 10.1016/j.vaccine.2018.04.089. Epub 2018 May 18.

2.

Correction: Distinct Roles of Type I and Type III Interferons in Intestinal Immunity to Homologous and Heterologous Rotavirus Infections.

Lin JD, Feng N, Sen A, Balan M, Tseng HC, McElrath C, Smirnov SV, Peng J, Yasukawa LL, Durbin RK, Durbin JE, Greenberg HB, Kotenko SV.

PLoS Pathog. 2016 Jun 15;12(6):e1005726. doi: 10.1371/journal.ppat.1005726. eCollection 2016 Jun.

3.

Distinct Roles of Type I and Type III Interferons in Intestinal Immunity to Homologous and Heterologous Rotavirus Infections.

Lin JD, Feng N, Sen A, Balan M, Tseng HC, McElrath C, Smirnov SV, Peng J, Yasukawa LL, Durbin RK, Durbin JE, Greenberg HB, Kotenko SV.

PLoS Pathog. 2016 Apr 29;12(4):e1005600. doi: 10.1371/journal.ppat.1005600. eCollection 2016 Apr. Erratum in: PLoS Pathog. 2016 Jun 15;12 (6):e1005726.

4.
5.

Animal models of respiratory syncytial virus infection and disease.

Sacco RE, Durbin RK, Durbin JE.

Curr Opin Virol. 2015 Aug;13:117-22. doi: 10.1016/j.coviro.2015.06.003. Epub 2015 Jul 11. Review.

6.

Interferon induction and function at the mucosal surface.

Durbin RK, Kotenko SV, Durbin JE.

Immunol Rev. 2013 Sep;255(1):25-39. doi: 10.1111/imr.12101. Review.

7.

Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo.

Jewell NA, Cline T, Mertz SE, Smirnov SV, Flaño E, Schindler C, Grieves JL, Durbin RK, Kotenko SV, Durbin JE.

J Virol. 2010 Nov;84(21):11515-22. doi: 10.1128/JVI.01703-09. Epub 2010 Aug 25. Erratum in: J Virol. 2011 Jan;85(1):650.

8.

Mapping the anatomy of respiratory syncytial virus infection of the upper airways in chinchillas (Chinchilla lanigera).

Grieves JL, Jurcisek JA, Quist B, Durbin RK, Peeples ME, Durbin JE, Bakaletz LO.

Comp Med. 2010 Jun;60(3):225-32.

9.

Methods used to study respiratory virus infection.

Flaño E, Jewell NA, Durbin RK, Durbin JE.

Curr Protoc Cell Biol. 2009 Jun;Chapter 26:Unit 26.3. doi: 10.1002/0471143030.cb2603s43.

10.

Influenza A virus inhibits alveolar fluid clearance in BALB/c mice.

Wolk KE, Lazarowski ER, Traylor ZP, Yu EN, Jewell NA, Durbin RK, Durbin JE, Davis IC.

Am J Respir Crit Care Med. 2008 Nov 1;178(9):969-76. doi: 10.1164/rccm.200803-455OC. Epub 2008 Aug 8.

11.

Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo.

Jewell NA, Vaghefi N, Mertz SE, Akter P, Peebles RS Jr, Bakaletz LO, Durbin RK, Flaño E, Durbin JE.

J Virol. 2007 Sep;81(18):9790-800. Epub 2007 Jul 11.

12.

Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge.

Tompkins SM, Lin Y, Leser GP, Kramer KA, Haas DL, Howerth EW, Xu J, Kennett MJ, Durbin RK, Durbin JE, Tripp R, Lamb RA, He B.

Virology. 2007 May 25;362(1):139-50. Epub 2007 Jan 23.

13.

Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector.

Martinez-Sobrido L, Gitiban N, Fernandez-Sesma A, Cros J, Mertz SE, Jewell NA, Hammond S, Flano E, Durbin RK, García-Sastre A, Durbin JE.

J Virol. 2006 Feb;80(3):1130-9.

14.

Role for innate IFNs in determining respiratory syncytial virus immunopathology.

Johnson TR, Mertz SE, Gitiban N, Hammond S, Legallo R, Durbin RK, Durbin JE.

J Immunol. 2005 Jun 1;174(11):7234-41.

15.

Chinchilla and murine models of upper respiratory tract infections with respiratory syncytial virus.

Gitiban N, Jurcisek JA, Harris RH, Mertz SE, Durbin RK, Bakaletz LO, Durbin JE.

J Virol. 2005 May;79(10):6035-42.

16.

Signaling through the prostaglandin I2 receptor IP protects against respiratory syncytial virus-induced illness.

Hashimoto K, Graham BS, Geraci MW, FitzGerald GA, Egan K, Zhou W, Goleniewska K, O'Neal JF, Morrow JD, Durbin RK, Wright PF, Collins RD, Suzutani T, Peebles RS Jr.

J Virol. 2004 Oct;78(19):10303-9.

17.

Respiratory syncytial virus-induced immunoprotection and immunopathology.

Durbin JE, Durbin RK.

Viral Immunol. 2004;17(3):370-80. Review.

PMID:
15357903
18.

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents.

Stojdl DF, Lichty BD, tenOever BR, Paterson JM, Power AT, Knowles S, Marius R, Reynard J, Poliquin L, Atkins H, Brown EG, Durbin RK, Durbin JE, Hiscott J, Bell JC.

Cancer Cell. 2003 Oct;4(4):263-75.

19.
20.

PKR protection against intranasal vesicular stomatitis virus infection is mouse strain dependent.

Durbin RK, Mertz SE, Koromilas AE, Durbin JE.

Viral Immunol. 2002;15(1):41-51.

PMID:
11952146
21.

The role of IFN in respiratory syncytial virus pathogenesis.

Durbin JE, Johnson TR, Durbin RK, Mertz SE, Morotti RA, Peebles RS, Graham BS.

J Immunol. 2002 Mar 15;168(6):2944-52.

22.
23.

The role of interferon in influenza virus tissue tropism.

García-Sastre A, Durbin RK, Zheng H, Palese P, Gertner R, Levy DE, Durbin JE.

J Virol. 1998 Nov;72(11):8550-8.

24.

Characterization of an unusual, sequence-specific termination signal for T7 RNA polymerase.

He B, Kukarin A, Temiakov D, Chin-Bow ST, Lyakhov DL, Rong M, Durbin RK, McAllister WT.

J Biol Chem. 1998 Jul 24;273(30):18802-11.

25.

Template strand switching by T7 RNA polymerase.

Rong M, Durbin RK, McAllister WT.

J Biol Chem. 1998 Apr 24;273(17):10253-60.

26.

Promoter specificity determinants of T7 RNA polymerase.

Rong M, He B, McAllister WT, Durbin RK.

Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):515-9.

27.

Rapid mutagenesis and purification of phage RNA polymerases.

He B, Rong M, Lyakhov D, Gartenstein H, Diaz G, Castagna R, McAllister WT, Durbin RK.

Protein Expr Purif. 1997 Feb;9(1):142-51.

PMID:
9116496
28.

A mutant T7 RNA polymerase that is defective in RNA binding and blocked in the early stages of transcription.

He B, Rong M, Durbin RK, McAllister WT.

J Mol Biol. 1997 Jan 24;265(3):275-88.

PMID:
9018042
29.

The stability of abortively cycling T7 RNA polymerase complexes depends upon template conformation.

Diaz GA, Rong M, McAllister WT, Durbin RK.

Biochemistry. 1996 Aug 20;35(33):10837-43.

PMID:
8718875
30.
31.

Characterization of two types of termination signal for bacteriophage T7 RNA polymerase.

Macdonald LE, Durbin RK, Dunn JJ, McAllister WT.

J Mol Biol. 1994 Apr 29;238(2):145-58.

PMID:
8158645
32.

Specific contacts between the bacteriophage T3, T7, and SP6 RNA polymerases and their promoters.

Jorgensen ED, Durbin RK, Risman SS, McAllister WT.

J Biol Chem. 1991 Jan 5;266(1):645-51.

33.

Regulated expression of nuclear genes by T3 RNA polymerase and lac repressor, using recombinant vaccinia virus vectors.

Rodriguez D, Zhou YW, Rodriguez JR, Durbin RK, Jimenez V, McAllister WT, Esteban M.

J Virol. 1990 Oct;64(10):4851-7.

34.

Synthesis of functional mRNA in mammalian cells by bacteriophage T3 RNA polymerase.

Zhou Y, Giordano TJ, Durbin RK, McAllister WT.

Mol Cell Biol. 1990 Sep;10(9):4529-37.

36.

SVLM21, a Sindbis virus mutant resistant to methionine deprivation, encodes an altered methyltransferase.

Scheidel LM, Durbin RK, Stollar V.

Virology. 1989 Dec;173(2):408-14.

PMID:
2596021
39.

Sindbis virus mutants resistant to mycophenolic acid and ribavirin.

Scheidel LM, Durbin RK, Stollar V.

Virology. 1987 May;158(1):1-7.

PMID:
3033882
41.

Sindbis virus mutants able to replicate in methionine-deprived Aedes albopictus cells.

Durbin RK, Stollar V.

Virology. 1985 Jul 30;144(2):529-33.

PMID:
4060595
42.
44.

The core of murine leukemia virus requires phosphate for structural stability.

Durbin RK, Manning JS.

Virology. 1982 Jan 15;116(1):31-9. No abstract available.

PMID:
7064343

Supplemental Content

Loading ...
Support Center